Malnutrition Screening and Diagnosis

Malnutrition screening and diagnosis is the two-stage process of first identifying people at nutritional risk with brief, validated screening tools and then confirming and characterising malnutrition through fuller assessment against standardised criteria. It links the assessment domains together and is the point at which nutritional data become a formal classification of nutritional status.

Definition

Malnutrition screening and diagnosis is the process of identifying nutritional risk with brief validated tools and then confirming malnutrition using standardised diagnostic criteria that integrate phenotypic and etiologic information.

Scope

The entry distinguishes screening from diagnosis, describes widely used screening instruments (such as NRS-2002, MUST, and the MNA-SF), and outlines the diagnostic frameworks (ASPEN/AND and GLIM) that combine phenotypic and etiologic criteria. It is a methodological and reference-educational topic; it explains how malnutrition is identified and classified and does not provide individualised diagnosis or treatment.

Core questions

• How does nutritional risk screening differ from diagnosing malnutrition?
• What phenotypic and etiologic criteria define malnutrition in current frameworks?
• How are validated screening tools selected and compared?

Key concepts

• Nutritional risk screening
• Two-step screening then assessment workflow
• Phenotypic criteria (weight loss, low BMI, reduced muscle mass)
• Etiologic criteria (reduced intake/assimilation, disease burden/inflammation)
• NRS-2002, MUST, and MNA-SF screening tools
• GLIM and ASPEN/AND diagnostic frameworks

Mechanisms

Screening applies short questionnaires - capturing recent weight change, intake, body mass index, and illness - to flag people who warrant fuller assessment; instruments such as NRS-2002, MUST, and the MNA-SF were validated for this purpose. Diagnosis then applies standardised criteria: the ASPEN/AND consensus lists characteristics such as insufficient intake, weight loss, and loss of muscle and fat, while the GLIM framework requires at least one phenotypic criterion (non-volitional weight loss, low BMI, or reduced muscle mass) together with at least one etiologic criterion (reduced intake or assimilation, or disease-related inflammation). This sequence converts assessment data into a reproducible classification.

Clinical relevance

Screening and diagnosis are how nutritional risk is recognised in clinical pathways and how malnutrition is documented for care and coding. As reference material this entry describes the tools and criteria and how they relate; it is descriptive of method and does not direct screening decisions or care for any individual.

Epidemiology

Disease-related malnutrition is highly prevalent across hospital, geriatric, and community populations, and its under-recognition motivated the development and validation of rapid screening tools and harmonised diagnostic criteria. The MNA-SF, for example, was developed specifically for geriatric practice, where undernutrition is common.

Evidence & guidelines

ESPEN guidelines for nutrition screening (Kondrup et al., 2003) introduced NRS-2002 and endorsed validated tools by setting; Skipper et al. (2011) reviewed the evidence base for screening instruments; Rubenstein et al. (2001) developed the MNA-SF. For diagnosis, the ASPEN/AND consensus (White et al., 2012) and the GLIM criteria (Cederholm et al., 2019) provide the principal frameworks.

History

Structured nutritional risk screening emerged in the early 2000s when ESPEN published validated tools including NRS-2002 and MUST, and the MNA family addressed geriatric settings. Diagnostic standardisation followed with the 2012 ASPEN/AND consensus and the 2019 GLIM criteria, which sought a single, globally applicable two-step scheme combining phenotypic and etiologic components.

Debates

Which screening tool should be used in a given setting?

NRS-2002, MUST, and the MNA-SF were validated for different populations and settings, and evidence reviews find no single tool is best everywhere, so selection depends on the care context.

Can the GLIM criteria be globally harmonised?

GLIM aimed to unify competing definitions, but the choice and thresholds of phenotypic and etiologic criteria, and how reduced muscle mass is measured, remain under active validation across populations.

Key figures

• Jens Kondrup
• Tommy Cederholm
• Gordon Jensen
• Annalynn Skipper
• Bruno Vellas

Seminal works

• kondrup-2003-nrs
• white-2012
• cederholm-2019-glim
• rubenstein-2001

Frequently asked questions

What is the difference between malnutrition screening and diagnosis?

Screening uses a brief, validated questionnaire to identify people who may be at nutritional risk and need further evaluation, whereas diagnosis applies fuller assessment against standardised criteria to confirm and characterise malnutrition.

What does the GLIM framework require to diagnose malnutrition?

GLIM uses a two-step approach: after screening, it requires at least one phenotypic criterion - non-volitional weight loss, low body mass index, or reduced muscle mass - together with at least one etiologic criterion, namely reduced food intake or assimilation, or disease-related inflammation.